Quarterly report pursuant to Section 13 or 15(d)

Stockholders Equity (Details) - Schedule of share-based payment expenses

v3.21.1
Stockholders Equity (Details) - Schedule of share-based payment expenses - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Schedule of share-based payment expenses [Abstract]    
Research and development expenses, net $ 331 $ 192
General and administrative 199 145
Share-based payment expenses, total $ 530 $ 337